IFIH1 was predicted as a key biomarker in primary Sjögren's syndrome based on transcriptome analysis and experimental verification in patients and mice

To investigate the novel key genes and biological processes that may lead to primary Sjögren’ s syndrome (pSS).

[1]  M. Horwitz,et al.  Changes in MDA5 and TLR3 Sensing of the Same Diabetogenic Virus Result in Different Autoimmune Disease Outcomes , 2021, Frontiers in Immunology.

[2]  Martin Kuiper,et al.  Gene Ontology representation for transcription factor functions. , 2021, Biochimica et Biophysica Acta. Gene Regulatory Mechanisms.

[3]  M. Kanehisa,et al.  KEGG mapping tools for uncovering hidden features in biological data , 2021, Protein science : a publication of the Protein Society.

[4]  R. Solans-Laqué,et al.  Pulmonary involvement in Sjögren's syndrome. , 2021, Medicina clinica.

[5]  B. Ni,et al.  Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis , 2021, Journal of Translational Medicine.

[6]  Shenmin Zhang,et al.  IFIH1 Contributes to M1 Macrophage Polarization in ARDS , 2021, Frontiers in Immunology.

[7]  F. Ferro,et al.  One year in review 2020: pathogenesis of primary Sjögren's syndrome. , 2020, Clinical and experimental rheumatology.

[8]  Renfu Quan,et al.  Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis , 2020, BioMed research international.

[9]  J. Gottenberg,et al.  Treatment of Sjögren's syndrome: current therapy and future directions. , 2021, Rheumatology.

[10]  Q. Qin,et al.  Identifying Key Genes and Functionally Enriched Pathways in Sjögren’s Syndrome by Weighted Gene Co-Expression Network Analysis , 2019, Front. Genet..

[11]  C. Mavragani,et al.  Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications. , 2019, Clinical and experimental rheumatology.

[12]  A. Vissink,et al.  Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's Syndrome , 2018, Arthritis & rheumatology.

[13]  S. Kamphuis,et al.  TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. , 2018, Journal of autoimmunity.

[14]  U. Urzúa,et al.  Impaired IRE1&agr;/XBP-1 pathway associated to DNA methylation might contribute to salivary gland dysfunction in Sjögren’s syndrome patients , 2018, Rheumatology.

[15]  A. Peck,et al.  What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome? , 2017, Clinical immunology.

[16]  F. Vivino.  Sjogren's syndrome: Clinical aspects. , 2017, Clinical immunology.

[17]  G. Gilkeson,et al.  Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. , 2017, Clinical immunology.

[18]  K. Kalunian,et al.  Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus , 2017, Arthritis & rheumatology.

[19]  P. J. van der Spek,et al.  Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.

[20]  Cathy H. Wu,et al.  Protein Bioinformatics Databases and Resources. , 2017, Methods in molecular biology.

[21]  M. Crow,et al.  Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease , 2016, Arthritis & rheumatology.

[22]  P. Seeburg,et al.  RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself , 2015, Science.

[23]  A. Vissink,et al.  Aging and Immunopathology in Primary Sjögren's Syndrome. , 2015, Current aging science.

[24]  T. Niewold,et al.  Dysregulation of antiviral helicase pathways in systemic lupus erythematosus , 2014, Front. Genet..

[25]  R. Jonsson,et al.  Implication of Epstein‐Barr Virus Infection in Disease‐Specific Autoreactive B Cell Activation in Ectopic Lymphoid Structures of Sjögren's Syndrome , 2014, Arthritis & rheumatology.

[26]  J. V. van Roon,et al.  Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome , 2014, Expert review of clinical immunology.

[27]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[28]  U. Urzúa,et al.  Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure. , 2010, Arthritis and rheumatism.

[29]  K. Ohmura,et al.  The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. , 2010, Rheumatology.

[30]  G. Baron,et al.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.

[31]  M. Ramos-Casals.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2010 .

[32]  H. Adle-Biassette,et al.  Pulmonary involvement in Sjögren’s syndrome , 2009 .

[33]  X. Mariette,et al.  B‐cell‐activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA‐activated protein kinase activation , 2009, European journal of immunology.

[34]  H. Drexhage,et al.  Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells , 2008, European journal of immunology.

[35]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[36]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.